Your browser doesn't support javascript.
Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19.
Li, Qiuyu; Cui, Cheng; Xu, Fei; Zhao, Jianping; Li, Nan; Li, Haichao; Wang, Tianbing; Zhang, Hua; Liu, Na; Wei, Yudong; Niu, Xiaoye; Xu, Yan; Dong, Jianping; Yao, Xueting; Wang, Xiaohong; Chen, Yahong; Li, Haiyan; Song, Chunli; Qiao, Jie; Liu, Dongyang; Shen, Ning.
  • Li Q; Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, China.
  • Cui C; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.
  • Xu F; Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
  • Zhao J; Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Li N; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, 100191, China.
  • Li H; Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, 100034, China.
  • Wang T; Trauma Center, Peking University People's Hospital, Beijing, 100044, China.
  • Zhang H; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, 100191, China.
  • Liu N; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.
  • Wei Y; Beijing Haidian Hospital, Haidian Section of Peking University Third Hospital, Beijing, 100080, China.
  • Niu X; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.
  • Xu Y; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.
  • Dong J; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.
  • Yao X; Beijing Haidian Hospital, Haidian Section of Peking University Third Hospital, Beijing, 100080, China.
  • Wang X; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.
  • Chen Y; Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, China.
  • Li H; Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, China.
  • Song C; Drug Clinical Trial Center, Peking University Third Hospital, Beijing, 100191, China.
  • Qiao J; Department of Cardiology, Peking University Third Hospital, Beijing, 100191, China.
  • Liu D; Institute of Medical Innovation, Peking University Third Hospital, Beijing, 100191, China.
  • Shen N; Institute of Medical Innovation, Peking University Third Hospital, Beijing, 100191, China.
Sci China Life Sci ; 64(4): 660-663, 2021 04.
Article in English | MEDLINE | ID: covidwho-1064582
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / COVID-19 Drug Treatment Type of study: Experimental Studies Limits: Humans Language: English Journal: Sci China Life Sci Journal subject: Biology / Science Year: 2021 Document Type: Article Affiliation country: S11427-020-1871-4

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / COVID-19 Drug Treatment Type of study: Experimental Studies Limits: Humans Language: English Journal: Sci China Life Sci Journal subject: Biology / Science Year: 2021 Document Type: Article Affiliation country: S11427-020-1871-4